English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17918/22935 (78%)
Visitors : 6798490      Online Users : 78
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23893


    Title: CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin alpha v beta 3 Axis
    Authors: Tsai, HC;Lai, YY;Hsu, HC;Fong, YC;Lien, MY;Tang, CH
    Keywords: CCL4;integrin;miR-3927-3p;metastasis;osteosarcoma
    Date: 2021
    Issue Date: 2022-08-05T09:44:34Z (UTC)
    Publisher: MDPI
    Abstract: Osteosarcoma is the most common type of primary malignant bone cancer, and it is associated with high rates of pulmonary metastasis. Integrin alpha v beta 3 is critical for osteosarcoma cell migratory and invasive abilities. Chemokine (C-C motif) ligand 4 (CCL4) has diverse effects on different cancer cells through its interaction with its specific receptor, C-C chemokine receptor type 5 (CCR5). Analysis of mRNA expression in human osteosarcoma tissue identified upregulated levels of CCL4, integrin alpha v and beta 3 expression. Similarly, an analysis of records from the Gene Expression Omnibus (GEO) dataset showed that CCL4 was upregulated in human osteosarcoma tissue. Importantly, the expression of both CCL4 and integrin alpha v beta 3 correlated positively with osteosarcoma clinical stages and lung metastasis. Analysis of osteosarcoma cell lines identified that CCL4 promotes integrin alpha v beta 3 expression and cell migration by activating the focal adhesion kinase (FAK), protein kinase B (AKT), and hypoxia inducible factor 1 subunit alpha (HIF-1 alpha) signaling pathways, which can downregulate microRNA-3927-3p expression. Pharmacological inhibition of CCR5 by maraviroc (MVC) prevented increases in integrin alpha v beta 3 expression and cell migration. This study is the first to implicate CCL4 as a potential target in the treatment of metastatic osteosarcoma.
    URI: http://dx.doi.org/10.3390/ijms222312737
    https://www.webofscience.com/wos/woscc/full-record/WOS:000735174400001
    https://ir.csmu.edu.tw:8080/handle/310902500/23893
    Relation: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ,2021,v22,issue 23
    Appears in Collections:[中山醫學大學研究成果] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML251View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback